Bioinformatic identification of previously unrecognized amyloidogenic proteins

[1]  M. P. Hughes,et al.  Identifying amyloid-related diseases by mapping mutations in low-complexity protein domains to pathologies , 2022, Nature Structural & Molecular Biology.

[2]  M. P. Hughes,et al.  Extended β-Strands Contribute to Reversible Amyloid Formation. , 2022, ACS nano.

[3]  S. McKnight,et al.  How do protein domains of low sequence complexity work? , 2021, RNA.

[4]  D. Eisenberg,et al.  The expanding amyloid family: Structure, stability, function, and pathogenesis , 2021, Cell.

[5]  Peter B. McGarvey,et al.  UniProt: the universal protein knowledgebase in 2021 , 2020, Nucleic Acids Res..

[6]  R. Tycko,et al.  Transiently structured head domains control intermediate filament assembly , 2020, Proceedings of the National Academy of Sciences.

[7]  S. McKnight,et al.  Dynamic structural order of a low-complexity domain facilitates assembly of intermediate filaments , 2020, Proceedings of the National Academy of Sciences.

[8]  E. Rogaeva,et al.  Neuropathologic description of CHCHD10 mutated amyotrophic lateral sclerosis , 2020, Neurology: Genetics.

[9]  D. Eisenberg,et al.  Structure-based inhibitors halt prion-like seeding by Alzheimer's disease–and tauopathy–derived brain tissue samples , 2019, The Journal of Biological Chemistry.

[10]  M. Batchelor,et al.  Desmin forms toxic, seeding-competent amyloid aggregates that persist in muscle fibers , 2019, Proceedings of the National Academy of Sciences.

[11]  B. Reif,et al.  Cysteine oxidation triggers amyloid fibril formation of the tumor suppressor p16INK4A , 2019, bioRxiv.

[12]  Alan F. Scott,et al.  OMIM.org: leveraging knowledge across phenotype–gene relationships , 2018, Nucleic Acids Res..

[13]  D. Eisenberg,et al.  Identification of two principal amyloid-driving segments in variable domains of Ig light chains in systemic light-chain amyloidosis , 2018, The Journal of Biological Chemistry.

[14]  R. Tycko,et al.  Structural characterization of the D290V mutation site in hnRNPA2 low-complexity–domain polymers , 2018, Proceedings of the National Academy of Sciences.

[15]  R. Pappu,et al.  A Molecular Grammar Governing the Driving Forces for Phase Separation of Prion-like RNA Binding Proteins , 2018, Cell.

[16]  S. Alberti,et al.  Prion-like low-complexity sequences: Key regulators of protein solubility and phase behavior , 2018, The Journal of Biological Chemistry.

[17]  E. L. Guenther,et al.  Atomic Structures of Segments from TDP-43 LCD and insight into Reversible and Pathogenic Aggregation , 2018, Nature Structural & Molecular Biology.

[18]  M. P. Hughes,et al.  Atomic structures of low-complexity protein segments reveal kinked β sheets that assemble networks , 2018, Science.

[19]  Nicolas L. Fawzi,et al.  Mechanistic View of hnRNPA2 Low-Complexity Domain Structure, Interactions, and Phase Separation Altered by Mutation and Arginine Methylation. , 2018, Molecular cell.

[20]  Chunlei Liu,et al.  ClinVar: improving access to variant interpretations and supporting evidence , 2017, Nucleic Acids Res..

[21]  K. Talbot,et al.  Pathogenesis of FUS-associated ALS and FTD: insights from rodent models , 2016, Acta Neuropathologica Communications.

[22]  C. Brangwynne,et al.  The disordered P granule protein LAF-1 drives phase separation into droplets with tunable viscosity and dynamics , 2015, Proceedings of the National Academy of Sciences.

[23]  S. Stagg,et al.  TFG clusters COPII‐coated transport carriers and promotes early secretory pathway organization , 2015, The EMBO journal.

[24]  Timothy D. Craggs,et al.  Phase Transition of a Disordered Nuage Protein Generates Environmentally Responsive Membraneless Organelles , 2015, Molecular cell.

[25]  P. Tsai,et al.  A novel TFG mutation causes Charcot-Marie-Tooth disease type 2 and impairs TFG function , 2014, Neurology.

[26]  N. Nukina,et al.  Intranuclear Aggregation of Mutant FUS/TLS as a Molecular Pathomechanism of Amyotrophic Lateral Sclerosis* , 2013, The Journal of Biological Chemistry.

[27]  Kun Huang,et al.  Disulfide bonds in amyloidogenesis diseases related proteins , 2013, Proteins.

[28]  Michael Benatar,et al.  Prion-like domain mutations in hnRNPs cause multisystem proteinopathy and ALS , 2013, Nature.

[29]  Stavros J. Hamodrakas,et al.  A Consensus Method for the Prediction of ‘Aggregation-Prone’ Peptides in Globular Proteins , 2013, PloS one.

[30]  S. Tsuji,et al.  The TRK-fused gene is mutated in hereditary motor and sensory neuropathy with proximal dominant involvement. , 2012, American journal of human genetics.

[31]  Jimin Pei,et al.  Cell-free Formation of RNA Granules: Low Complexity Sequence Domains Form Dynamic Fibers within Hydrogels , 2012, Cell.

[32]  J. Haines,et al.  Mutations in UBQLN2 cause dominant X-linked juvenile and adult onset ALS and ALS/dementia , 2011, Nature.

[33]  D. Seldin,et al.  Amyloidosis: pathogenesis and new therapeutic options. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[34]  Juliet A. Ellis,et al.  Novel LMNA mutations in patients with Emery‐Dreifuss muscular dystrophy and functional characterization of four LMNA mutations , 2011, Human mutation.

[35]  David Eisenberg,et al.  Identifying the amylome, proteins capable of forming amyloid-like fibrils , 2010, Proceedings of the National Academy of Sciences.

[36]  John Q Trojanowski,et al.  Mutations in TDP-43 link glycine-rich domain functions to amyotrophic lateral sclerosis. , 2009, Human molecular genetics.

[37]  L. Serpell,et al.  Amyloid fibrils , 2008, Prion.

[38]  Christina Zeitz,et al.  Night blindness–associated mutations in the ligand‐binding, cysteine‐rich, and intracellular domains of the metabotropic glutamate receptor 6 abolish protein trafficking , 2007, Human mutation.

[39]  A. Wills,et al.  Oculopharyngeal muscular dystrophy: a point mutation which mimics the effect of the PABPN1 gene triplet repeat expansion mutation , 2005, Journal of Medical Genetics.

[40]  M. R. Nilsson.  Techniques to study amyloid fibril formation in vitro. , 2004, Methods.

[41]  R. Rudolph,et al.  Trinucleotide expansions leading to an extended poly‐l‐alanine segment in the poly (A) binding protein PABPN1 cause fibril formation , 2003, Protein science : a publication of the Protein Society.

[42]  H. Levine.  Quantification of beta-sheet amyloid fibril structures with thioflavin T. , 1999, Methods in enzymology.

[43]  C. Deber,et al.  Alpha-helical, but not beta-sheet, propensity of proline is determined by peptide environment. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[44]  John C. Wootton,et al.  Statistics of Local Complexity in Amino Acid Sequences and Sequence Databases , 1993, Comput. Chem..

[45]  M. Levitt.  Conformational preferences of amino acids in globular proteins. , 1978, Biochemistry.